LESCOL

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, United States, South Africa

Active ingredients

The drug LESCOL contains one active pharmaceutical ingredient (API):

1 Fluvastatin UNII PYF7O1FV7F - FLUVASTATIN SODIUM

Fluvastatin, a fully synthetic cholesterol-lowering agent, is a competitive inhibitor of HMG-CoA reductase, which is responsible for the conversion of HMG-CoA to mevalonate, a precursor of sterols, including cholesterol. Fluvastatin reduces total-C, LDL-C, Apo B, and triglycerides, and increases HDL-C in patients with hypercholesterolaemia and mixed dyslipidaemia. Read about Fluvastatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LESCOL XL Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10AA04	Fluvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2863Q, 9236D
Country: CA	Health Products and Food Branch	Identifier(s): 02250527
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 13427562, 13987516
Country: EE	Ravimiamet	Identifier(s): 1011126, 1060816, 1060827, 1678057, 1678068, 1678079, 1685976, 1685987, 1685998, 1686001, 1686012, 1686023, 1686034, 1686045, 1686056, 1686067, 1686078, 1686089, 1686090, 1686102, 1686113, 1686124, 1686135, 1686146, 1686157, 1686168, 1686179, 1686180, 1686191, 1686203, 1686214, 1686225, 1686595, 1686630, 1723193, 1723205, 1723216, 1723227, 1723238, 1723249, 1723250, 1723261, 1723272, 1723283, 1723294, 1723306, 1723317, 1723328, 1723339, 1723340, 1723351, 1881020, 1881031, 1881042, 1881053, 1881064, 1881075, 1881086, 1881097, 1881109, 1881110, 1881121, 1881165
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64648
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 011986, 011997
Country: FR	Base de données publique des médicaments	Identifier(s): 60852004
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 13881, 147667
Country: IE	Health Products Regulatory Authority	Identifier(s): 39256, 77104
Country: IT	Agenzia del Farmaco	Identifier(s): 029163033
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003486, 1067686, 1068279, 1068280, 1068281, 1068282, 1068283, 1068284, 1068285, 1068286, 1068287, 1068288, 1068289, 1068290, 1068291, 1068292, 1068293, 1068294, 1068295, 1068296, 1091102
Country: MT	Medicines Authority	Identifier(s): PI908/00401A
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 59161
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 9691
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100037224, 100037230, 100103056
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51412001, W51412002, W51412003, W51412004, W51412005, W51412006, W51412007, W51412008, W51412009, W51412010, W51412011, W51412012, W51412013, W51412014, W51412015, W51412016, W51412017, W51412018, W51412019, W51412020, W51412021, W51412022, W51412023, W51412024, W51412025, W51412026
Country: SG	Health Sciences Authority	Identifier(s): 11496P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 102830231
Country: US	FDA, National Drug Code	Identifier(s): 0078-0354
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/7.5/0159, 28/7.5/0160, 35/7.5/0327